Obagi Medical debuted its NU-GEN Cellular Renewal Serum on Mar 24, 2026 — a longevity-driven skincare product that incorporates the NAD+ molecule.
While NAD+ has been widely discussed in the context of cellular aging and longevity, Obagi is among the first brands to successfully formulate it directly into a topical, paired with its proprietary AGE CTRL Complex to help replenish declining cellular energy in the skin.
The result is a next-generation serum designed to target nine visible signs of skin aging at the cellular level, from tone and texture to firmness and radiance:
Related: New At-Home Smart NAD+ Injection Pen Promises Easier Infusions
- In clinical studies, NU-GEN showed a 51% improvement in skin tone evenness and up to a 30% reduction in fine lines and wrinkles
- Delivers a 49% boost in radiance and clinically proven hydration benefits in as little as 30 minutes
- Demonstrated improvements across blemishes, redness, firmness, and barrier strength, making it relevant beyond traditional “anti-aging” positioning
This launch marks a significant shift toward longevity skincare, moving beyond surface-level actives to address how skin cells function and regenerate over time.
NU-GEN is available starting today via Obagi.com
